Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Earnings save search
Nuo Therapeutics Provides Corporate and Business Update
Published: 2022-08-30 (Crawled : 13:00) - biospace.com/
AURX 4 | $0.95 116.67% 1K
|
|
| O: 7.41%
H: 48.28%
C: 48.28%
therapeutics update
Q BioMed Shows Significant Uptrend in Revenues in Year-End Update
Published: 2021-12-16 (Crawled : 14:30) - biospace.com/
QBIO | $0.0003 100.0% 30K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 47.83%
C: 44.93%
TG Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results
Published: 2022-11-10 (Crawled : 18:00) - biospace.com/
TGTX | $13.825 -1.25% -1.27% 3.1M
|
Health Technology
|
| O: 12.98%
H: 51.63%
C: 44.6%
therapeutics financial update results
Fulcrum Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results
Published: 2021-08-10 (Crawled : 13:00) - biospace.com/
FULC | $7.15 -3.51% -3.49% 400K
|
Health Technology
|
| O: 58.58%
H: 67.22%
C: 42.09%
financial results results
AquaBounty Technologies Announces Results for the Quarter and Year Ended December 31, 2021
Published: 2022-03-10 (Crawled : 18:00) - biospace.com/
AQB | $1.7475 0.43% -0.57% 4.9K
|
Health Technology
|
| O: -2.86%
H: 50.74%
C: 41.91%
ces results
InfuSystem Reports First Quarter 2022 Financial Results
Published: 2022-05-05 (Crawled : 12:00) - biospace.com/
STMH | $0.1 -88.3% 0
|
Manufacturing
|
| O: 0.0%
H: 49.0%
C: 39.5%
results
QSAM Biosciences Reports First Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-05-17 (Crawled : 13:20) - biospace.com/
QSAM | $7.4 -31.58% 3.6K
|
Manufacturing
|
| O: -14.8%
H: 36.38%
C: 36.38%
results
Revance Provides an Update on DAXXIFY® Commercial Launch and Preliminary Fourth Quarter and Full Year 2022 Financial Results
Published: 2023-01-09 (Crawled : 19:00) - biospace.com/
VTRS | $11.095 -0.22% -0.23% 6.1M
|
Health Technology
|
| O: 0.17%
H: 0.58%
C: -0.91%
RVNC | $3.76 -1.31% -1.87% 1.7M
|
Health Technology
|
| O: 15.12%
H: 34.86%
C: 34.07%
daxxify commercial year financial update results
ANI Pharmaceuticals Reports Third Quarter 2021 Results
Published: 2021-11-01 (Crawled : 12:00) - biospace.com/
ANIP S | $65.48 -0.12% -0.09% 120K
|
Health Technology
|
| O: 9.77%
H: 41.84%
C: 31.63%
results
Sharecare announces second quarter 2022 financial results and operational highlights
Published: 2022-08-10 (Crawled : 12:20) - biospace.com/
SHCR | $0.6617 -1.25% -1.53% 2.4M
|
|
| O: -7.28%
H: 32.14%
C: 30.71%
results
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2020 Results Strengthens Balance Sheet Through Amendment of Loan Agreement with CRG
Published: 2021-01-26 (Crawled : 23:00) - biospace.com/
TTOO A | $2.94 -2.97% -3.06% 62K
|
Health Technology
|
| O: 3.27%
H: 34.01%
C: 28.96%
results
Epizyme Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Published: 2022-03-01 (Crawled : 13:00) - biospace.com/
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
|
| O: -15.54%
H: 29.6%
C: 27.2%
financial results report results
RAPT Therapeutics Reports Third Quarter 2022 Financial Results
Published: 2022-11-10 (Crawled : 17:00) - biospace.com/
RAPT | $8.04 -1.11% -1.5% 630K
|
Health Technology
|
| O: 0.11%
H: 29.24%
C: 26.03%
therapeutics financial results
Deciphera Pharmaceuticals, Inc. Announces Second Quarter 2022 Financial Results
Published: 2022-08-04 (Crawled : 12:00) - biospace.com/
DCPH | $14.72 -0.81% -0.82% 380K
|
Health Technology
|
| O: -1.62%
H: 27.12%
C: 25.92%
results
Venus Concept to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 29, 2021
Published: 2021-02-08 (Crawled : 22:00) - biospace.com/
VERO | $0.8103 -2.37% -2.43% 55K
|
Health Technology
|
| O: 1.4%
H: 25.69%
C: 25.23%
results financial results
Nanox Announces Its First Quarter of 2022 Financial Results and Provides Business Update
Published: 2022-05-19 (Crawled : 13:00) - biospace.com/
NNOX | $9.35 0.86% 0.96% 880K
|
Health Technology
|
| O: -8.71%
H: 26.04%
C: 24.8%
results
RedHill Biopharma Reports Operational Highlights and Fourth Quarter & Full Year 2021 Financial Results
Published: 2022-03-17 (Crawled : 13:00) - biospace.com/
RDHL | $0.3855 0.13% 2.16% 240K
|
Health Technology
|
| O: 0.0%
H: 30.05%
C: 24.59%
biopharma financial results report results tiona
CEL-SCI Corporation Reports Third Quarter Fiscal 2022 Financial Results
Published: 2022-08-15 (Crawled : 14:00) - biospace.com/
CVM | $1.5 -1.32% 0.0% 130K
|
Health Technology
|
| O: 0.72%
H: 28.95%
C: 24.52%
corporation results
Aptevo Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights
Published: 2022-05-12 (Crawled : 13:00) - biospace.com/
APVO 2 d | $0.7125 -7.23% -7.26% 410K
|
Health Technology
|
| O: -6.5%
H: 26.38%
C: 23.19%
therapeutics results
MedAvail Reports Fourth Quarter and Full-Year 2022 Financial Results
Published: 2023-04-13 (Crawled : 23:00) - biospace.com/
MDVL 4 | $1.8 -0.56% 250K
|
Health Technology
|
| O: 5.88%
H: 42.96%
C: 22.22%
financial results
Gainers vs Losers
| 57% | 43% |
Top 10 Gainers
INVO | $1.82 139.47% 56.82% 220M
|
Health Technology
SINT | $0.0373 62.88% 37.26% 460M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.66 46.37% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 600K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
SRFM 4 | $0.3859 -12.3% 23.84% 660K
|
n/a
KZIA | $0.3442 18.28% 23.42% 290K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.